More Articles

Increased use of generic statins proves cost effective in Australia Generics/Research | Posted 25/05/2012

A recent study concluded that closing the statin ‘treatment gap’ using generics was cost-effective in the secondary prevention of coronary artery disease (CAD) in Australia [1].

Immunogenicity of biologicals Biosimilars/Research | Posted 25/05/2012

This article discusses the issue of immunogenicity with respect to originator biologicals and biosimilars [1].

Generics makers cannot gain access to some brand-name drugs Generics/News | Posted 25/05/2012

Generics manufacturers trying to create generics for certain drugs are having problems gaining access to samples of the brand-name drugs due to restrictions on supply put in place by FDA.

APPG reports on drug shortages and MHRA bans unlicensed stock trading Pharma News | Posted 25/05/2012

On 14 May 2012, the All-Party Pharmacy Group (APPG) published the results of its inquiry into drug shortages in the UK. In response to this the Medicines and Healthcare products Regulatory Agency (...

Generics sustainability to be investigated by UK DoH and industry Generics/General | Posted 25/05/2012

The British Generic Manufacturers Association (BGMA) and the UK Department of Health (DoH) have agreed to work together to investigate potential challenges to the sustainability of the generics ind...

US Senator calls for prizes not patents for drug discovery Policies & Legislation | Posted 25/05/2012

A radical idea has been proposed by a US Senator calling for patents on drugs to be scrapped and instead an annual prize fund set up, which would reward the discovery of new treatments. These treat...

US Supreme Court looks set to challenge Affordable Care Act Biosimilars/General | Posted 18/05/2012

The United States Supreme Court is reviewing the constitutionality of the provision in the Affordable Care Act providing that individuals should take personal responsibility for paying for their he...

Clopidogrel goes off-patent: last of the old-style blockbusters Generics/General | Posted 18/05/2012

The blockbuster drug Plavix (clopidogrel), used to prevent clotting in some heart patients, comes off patent in the US on 17 May 2012, bringing to an end the run of spectacularly well-selling tradi...